26,27 Suggestive evidence of hemoglobin A1c-lowering being the cause of the reported worsening with GLP-1/GIP agonists can be derived by comparing the results of two recent retrospective cohort studies assessing retinopathy outcomes between subjects treated with GLP-1/GIP agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors
When compared to couples with unexplained infertility, IUI and ovarian stimulation appeared less effective for people with endometriosis
Oral GLP1RAs are also beginning to reach clinical practice, and will open up access for those who do not want, or cannot have, injections
Entre el 13 de septiembre y el 22 de noviembre de 2021, se realizaron pruebas a un total de 709 individuos, de los cuales 667 fueron incluidos en el estudio
( Wegovy, a brand name GLP-A, was approved by Health Canada for an additional indication to treat a liver condition called metabolic dysfunction-associated steatohepatitis on Dec